Updates are available Correction dated 2024-11-09
Click to view Correction: https://doi.org/10.1007/s13300-024-01666-8
-
Authors
Di Molfetta, Sergio https://orcid.org/0000-0003-3454-7330
Rossi, Antonio https://orcid.org/0000-0002-8660-2146
Boscari, Federico https://orcid.org/0000-0002-9670-615X
Irace, Concetta https://orcid.org/0000-0001-5182-5473
Laviola, Luigi https://orcid.org/0000-0001-8860-5845
Bruttomesso, Daniela https://orcid.org/0000-0002-2426-8955
- License Information
-
More Information
Article History
Received: 12 July 2024
Accepted: 9 September 2024
First Online: 30 September 2024
Change Date: 9 November 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s13300-024-01666-8
Declarations
:
: Sergio di Molfetta has received consulting fees from Roche Diabetes Care, Ascensia Diabetes Care, and Eli Lilly and received payment or honoraria for lectures, presentations, spekers bureaus, manuscript writing or education events from Movi S.p.A and Ascensia Diabetes Care. Antonio Rossi, in the last two years, has received speaking and/or consulting fees from AstraZeneza, Roche Diabetes Care, Menarini Diagnostics, Alpha Pharma, Abbott, Sanofi, and Theras. Federico Boscari has received consulting fees from Roche, and Glooko and received honoraria for lectures and presentations from Roche, Novo Nordisk, Sanofi Aventis, and Movi. Concetta Irace has provided advisory board services for Novo Nordisk, Lilly, Roche Diabetes Care Italy, Abbott, Menarini, Ascensia, and Senseonics and has received speaker fees from Novo Nordisk, Roche Diabetes Care Italy, Abbott, Ascensia, Lilly, and Boehringer Ingelheim Pharmaceuticals. Luigi Laviola has received consulting fees from Abbott, Boehringer Ingelheim, AstraZeneca, Eli Lilly Italia, GSK, Medtronic, Menarini, MOVI, Novo Nordisk, Roche Diabetes Care, Sanofi and honoraria for lectures and presentations from Abbott, Boehringer Ingelheim, AstraZeneca, Eli Lilly Italia, Medtronic, Menarini, MOVI, Mundipharma, Novo Nordisk, Roche Diabetes Care, Sanofi. Daniela Bruttomesso has received consulting fees from Menarini, Novo Nordisk, Roche, and Terumo and received honoraria for lectures and presentations from Abbott, Eli Lilly, Novo Nordisk, Roche, Sanofi Aventis, and Theras.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
